The S&P 500 retreats, crude gains as vaccine hopes boost recovery bets

By Stephen Culp NEW YORK (Reuters) - The S&P 500 and the Nasdaq retreated on Tuesday and oil prices extended the previous session's surge as promising developments toward an effective COVID-19 vaccine led investors away from market leaders and toward cyclical stocks associated with economic recovery. The blue-chip Dow, buoyed by industrial shares, gained ground and crude advanced as investors bet on a demand rebound

Reuters November 11, 2020 02:05:49 IST
The S&P 500 retreats, crude gains as vaccine hopes boost recovery bets

The SP 500 retreats crude gains as vaccine hopes boost recovery bets

By Stephen Culp

NEW YORK (Reuters) - The S&P 500 and the Nasdaq retreated on Tuesday and oil prices extended the previous session's surge as promising developments toward an effective COVID-19 vaccine led investors away from market leaders and toward cyclical stocks associated with economic recovery.

The blue-chip Dow, buoyed by industrial shares, gained ground and crude advanced as investors bet on a demand rebound.

Pfizer Inc announced on Monday that its COVID-19 vaccine candidate, developed with German partner BioNTech , showed in trials it had a 90% success rate in preventing infection.

The development led to investors taking profits from market-leading tech stocks that have thrived amid the pandemic recession.

"The rotation away from COVID beneficiaries to beneficiaries of a more open economy continues today," said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. "Some of the things that were expensive and tied to the work-from-home economy seem to be suffering a bit.

"The Pfizer news really surprised everyone yesterday and put a light at the end of the tunnel," Tuz added. "That tunnel may be 12 months long or 6 months long, but it suggests that life is going to get back to what it was before COVID started."

The Dow Jones Industrial Average <.DJI> rose 230.92 points, or 0.79%, to 29,388.89, the S&P 500 <.SPX> lost 6.6 points, or 0.19%, to 3,543.9 and the Nasdaq Composite <.IXIC> dropped 157.55 points, or 1.35%, to 11,556.23.

European shares extended their gains on lingering vaccine optimism and news that EU negotiators have agreed on a budget, a crucial step toward activating the bloc's 1.8 trillion euro recovery package.

The pan-European STOXX 600 index <.STOXX> rose 0.90% and MSCI's gauge of stocks across the globe <.MIWD00000PUS> shed 0.02%.

Emerging market stocks lost 1.11%. MSCI's broadest index of Asia-Pacific shares outside Japan <.MIAPJ0000PUS> closed 0.68% lower, while Japan's Nikkei <.N225> rose 0.26%.

U.S. Treasury yields inched higher on Tuesday in choppy trading, consolidating the previous session's gains due to economic optimism in the wake of positive news on a potential coronavirus vaccine.

Benchmark 10-year notes last fell 3/32 in price to yield 0.9664%, from 0.958% late on Monday.

The 30-year bond last fell 2/32 in price to yield 1.7529%, from 1.751% late on Monday.

Oil prices extended Monday's surge, which gave the commodity its biggest daily percentage gain in five months, as views of a possible medical solution to the pandemic outweighed sagging demand from new lockdowns to contain the virus.

U.S. crude rose 2.66% to settle at $41.36 per barrel, while Brent settled at $43.61 per barrel, up 2.85% on the day.

The dollar held its ground against a basket of currencies as the forex markets absorbed Monday's big moves due to vaccine developments.

The dollar index <.DXY> fell 0.02%, with the euro up 0.07% to $1.1821.

The Japanese yen strengthened 0.08% versus the greenback at 105.30 per dollar, while Sterling was last trading at $1.3252, up 0.68% on the day.

Gold regained some ground lost in Monday's plunge expectations of fiscal and monetary stimulus offered support to the safe-haven metal.

Spot gold added 0.8% to $1,876.91 an ounce.

(Reporting by Stephen Culp; additional reporting by Marc Jones; Editing by Dan Grebler and Nick Zieminski)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. job openings rise slightly in September
Business

U.S. job openings rise slightly in September

WASHINGTON (Reuters) - U.S. job openings increased moderately in September and layoffs appeared to abate, pointing to a gradual labor market recovery from the COVID-19 pandemic.

Central bankers seek new role in brave new world
Business

Central bankers seek new role in brave new world

By Balazs Koranyi and Francesco Canepa FRANKFURT (Reuters) - Taking a break from fighting the coronavirus crisis, the world's top central bankers will attempt to resolve the existential questions of their profession this week as they tune into the European Central Bank's annual policy symposium. Having struggled to lift anaemic inflation for years, officials including the heads of the ECB, the U.S. Federal Reserve and the Bank of England will attempt to figure out why monetary policy is not working as it used to and what new role they must play in a changed world - be it fighting inequality or climate change.

Asian stocks extend gains as vaccine hopes support global reopening
Business

Asian stocks extend gains as vaccine hopes support global reopening

By Lawrence Delevingne BOSTON (Reuters) - Asian shares rose on Wednesday as hopes for a successful coronavirus vaccine lifted expectations of a swift reopening of the global economy, which would help the region's heavily trade-dependent markets.